Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells

Ke Li, Dehuang Guo, Haidong Zhu, Kathleen S. Hering-Smith, L. Lee Hamm, Jingping Ouyang, Yanbin Dong

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The aim of this study is to elucidate the effects of interleukin-6 (IL-6) on the expression and activity of the epithelial sodium channel (ENaC), which is one of the key mechanisms underlying tubular sodium reabsorption. M-1 cortical collecting duct cells were treated with IL-6 (100 ng/ml) for 12 h. Real-time polymerase chain reaction and immunoblotting were employed to examine the mRNA and protein abundance. Transepithelial voltage (Vte) and resistance (Rte) were measured with an ohm/ voltmeter (EVOM, WPI). The equivalent current was calculated as the ratio of Vte to R te. Treatment with IL-6 (n = 5) increased the mRNA abundance of α-ENaC by 11 ± 7% (P = not significant), β-ENaC by 78 ± 14% (P = 0.01), γ-ENaC by 185 ± 38% (P = 0.02), and prostasin by 29 ± 5% (P = 0.01), all normalized by β-actin. Treatment with IL-6 increased the protein expression of α-ENaC by 19 ± 3% (P = 0.001), β-ENaC by 89 ± 21% (P = 0.01), γ-ENaC by 36 ± 12% (P = 0.02), and prostasin by 33 ± 6% (P = 0.02). The amiloride-sensitive sodium current increased by 37 ± 5%, from 6.0 ± 0.4 to 8.2 ± 0.3 μA/cm2 (P < 0.01), in the cells treated with IL-6 compared with controls (P = 0.01). Aprotinin (28 μg/ml), a prostasin inhibitor, reduced the amiloride-sensitive sodium current by 61 ± 5%, from 6.1 ± 0.3 to 3.7 ± 0.2 μA/cm2 (P = 0.01). The magnitude of the IL-6-induced amiloride-sensitive sodium current in the presence of aprotinin dropped by 57 ± 2%, from 8.6 ± 0.2 to 4.9 ± 0.2 μA/cm2 (P = 0.01). This study has identified a novel function of IL-6, namely, IL-6 may activate ENaC. Therefore, renal inflammation mediated by IL-6 likely contributes to impaired pressure natriuresis.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume299
Issue number2
DOIs
StatePublished - Aug 1 2010

Fingerprint

Epithelial Sodium Channels
Interleukin-6
Amiloride
Sodium
Aprotinin
Messenger RNA
Natriuresis
Immunoblotting
Actins
Real-Time Polymerase Chain Reaction
Proteins
Inflammation
Kidney
Pressure

Keywords

  • Distal tubule
  • Pressure natriuresis
  • Prostasin

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells. / Li, Ke; Guo, Dehuang; Zhu, Haidong; Hering-Smith, Kathleen S.; Hamm, L. Lee; Ouyang, Jingping; Dong, Yanbin.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 299, No. 2, 01.08.2010.

Research output: Contribution to journalArticle

@article{b8e89a7cb9f04eceb541add5bbf82d90,
title = "Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells",
abstract = "The aim of this study is to elucidate the effects of interleukin-6 (IL-6) on the expression and activity of the epithelial sodium channel (ENaC), which is one of the key mechanisms underlying tubular sodium reabsorption. M-1 cortical collecting duct cells were treated with IL-6 (100 ng/ml) for 12 h. Real-time polymerase chain reaction and immunoblotting were employed to examine the mRNA and protein abundance. Transepithelial voltage (Vte) and resistance (Rte) were measured with an ohm/ voltmeter (EVOM, WPI). The equivalent current was calculated as the ratio of Vte to R te. Treatment with IL-6 (n = 5) increased the mRNA abundance of α-ENaC by 11 ± 7{\%} (P = not significant), β-ENaC by 78 ± 14{\%} (P = 0.01), γ-ENaC by 185 ± 38{\%} (P = 0.02), and prostasin by 29 ± 5{\%} (P = 0.01), all normalized by β-actin. Treatment with IL-6 increased the protein expression of α-ENaC by 19 ± 3{\%} (P = 0.001), β-ENaC by 89 ± 21{\%} (P = 0.01), γ-ENaC by 36 ± 12{\%} (P = 0.02), and prostasin by 33 ± 6{\%} (P = 0.02). The amiloride-sensitive sodium current increased by 37 ± 5{\%}, from 6.0 ± 0.4 to 8.2 ± 0.3 μA/cm2 (P < 0.01), in the cells treated with IL-6 compared with controls (P = 0.01). Aprotinin (28 μg/ml), a prostasin inhibitor, reduced the amiloride-sensitive sodium current by 61 ± 5{\%}, from 6.1 ± 0.3 to 3.7 ± 0.2 μA/cm2 (P = 0.01). The magnitude of the IL-6-induced amiloride-sensitive sodium current in the presence of aprotinin dropped by 57 ± 2{\%}, from 8.6 ± 0.2 to 4.9 ± 0.2 μA/cm2 (P = 0.01). This study has identified a novel function of IL-6, namely, IL-6 may activate ENaC. Therefore, renal inflammation mediated by IL-6 likely contributes to impaired pressure natriuresis.",
keywords = "Distal tubule, Pressure natriuresis, Prostasin",
author = "Ke Li and Dehuang Guo and Haidong Zhu and Hering-Smith, {Kathleen S.} and Hamm, {L. Lee} and Jingping Ouyang and Yanbin Dong",
year = "2010",
month = "8",
day = "1",
doi = "10.1152/ajpregu.00207.2009",
language = "English (US)",
volume = "299",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells

AU - Li, Ke

AU - Guo, Dehuang

AU - Zhu, Haidong

AU - Hering-Smith, Kathleen S.

AU - Hamm, L. Lee

AU - Ouyang, Jingping

AU - Dong, Yanbin

PY - 2010/8/1

Y1 - 2010/8/1

N2 - The aim of this study is to elucidate the effects of interleukin-6 (IL-6) on the expression and activity of the epithelial sodium channel (ENaC), which is one of the key mechanisms underlying tubular sodium reabsorption. M-1 cortical collecting duct cells were treated with IL-6 (100 ng/ml) for 12 h. Real-time polymerase chain reaction and immunoblotting were employed to examine the mRNA and protein abundance. Transepithelial voltage (Vte) and resistance (Rte) were measured with an ohm/ voltmeter (EVOM, WPI). The equivalent current was calculated as the ratio of Vte to R te. Treatment with IL-6 (n = 5) increased the mRNA abundance of α-ENaC by 11 ± 7% (P = not significant), β-ENaC by 78 ± 14% (P = 0.01), γ-ENaC by 185 ± 38% (P = 0.02), and prostasin by 29 ± 5% (P = 0.01), all normalized by β-actin. Treatment with IL-6 increased the protein expression of α-ENaC by 19 ± 3% (P = 0.001), β-ENaC by 89 ± 21% (P = 0.01), γ-ENaC by 36 ± 12% (P = 0.02), and prostasin by 33 ± 6% (P = 0.02). The amiloride-sensitive sodium current increased by 37 ± 5%, from 6.0 ± 0.4 to 8.2 ± 0.3 μA/cm2 (P < 0.01), in the cells treated with IL-6 compared with controls (P = 0.01). Aprotinin (28 μg/ml), a prostasin inhibitor, reduced the amiloride-sensitive sodium current by 61 ± 5%, from 6.1 ± 0.3 to 3.7 ± 0.2 μA/cm2 (P = 0.01). The magnitude of the IL-6-induced amiloride-sensitive sodium current in the presence of aprotinin dropped by 57 ± 2%, from 8.6 ± 0.2 to 4.9 ± 0.2 μA/cm2 (P = 0.01). This study has identified a novel function of IL-6, namely, IL-6 may activate ENaC. Therefore, renal inflammation mediated by IL-6 likely contributes to impaired pressure natriuresis.

AB - The aim of this study is to elucidate the effects of interleukin-6 (IL-6) on the expression and activity of the epithelial sodium channel (ENaC), which is one of the key mechanisms underlying tubular sodium reabsorption. M-1 cortical collecting duct cells were treated with IL-6 (100 ng/ml) for 12 h. Real-time polymerase chain reaction and immunoblotting were employed to examine the mRNA and protein abundance. Transepithelial voltage (Vte) and resistance (Rte) were measured with an ohm/ voltmeter (EVOM, WPI). The equivalent current was calculated as the ratio of Vte to R te. Treatment with IL-6 (n = 5) increased the mRNA abundance of α-ENaC by 11 ± 7% (P = not significant), β-ENaC by 78 ± 14% (P = 0.01), γ-ENaC by 185 ± 38% (P = 0.02), and prostasin by 29 ± 5% (P = 0.01), all normalized by β-actin. Treatment with IL-6 increased the protein expression of α-ENaC by 19 ± 3% (P = 0.001), β-ENaC by 89 ± 21% (P = 0.01), γ-ENaC by 36 ± 12% (P = 0.02), and prostasin by 33 ± 6% (P = 0.02). The amiloride-sensitive sodium current increased by 37 ± 5%, from 6.0 ± 0.4 to 8.2 ± 0.3 μA/cm2 (P < 0.01), in the cells treated with IL-6 compared with controls (P = 0.01). Aprotinin (28 μg/ml), a prostasin inhibitor, reduced the amiloride-sensitive sodium current by 61 ± 5%, from 6.1 ± 0.3 to 3.7 ± 0.2 μA/cm2 (P = 0.01). The magnitude of the IL-6-induced amiloride-sensitive sodium current in the presence of aprotinin dropped by 57 ± 2%, from 8.6 ± 0.2 to 4.9 ± 0.2 μA/cm2 (P = 0.01). This study has identified a novel function of IL-6, namely, IL-6 may activate ENaC. Therefore, renal inflammation mediated by IL-6 likely contributes to impaired pressure natriuresis.

KW - Distal tubule

KW - Pressure natriuresis

KW - Prostasin

UR - http://www.scopus.com/inward/record.url?scp=77955496827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955496827&partnerID=8YFLogxK

U2 - 10.1152/ajpregu.00207.2009

DO - 10.1152/ajpregu.00207.2009

M3 - Article

VL - 299

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 2

ER -